Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 5 | 2022 | 237 | 1.180 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2022 | 692 | 0.770 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 372 | 0.650 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 280 | 0.650 |
Why?
|
| Chemoradiotherapy | 3 | 2022 | 104 | 0.260 |
Why?
|
| Oncolytic Virotherapy | 1 | 2024 | 84 | 0.220 |
Why?
|
| Metagenome | 2 | 2022 | 148 | 0.220 |
Why?
|
| Adenoviridae | 1 | 2024 | 604 | 0.190 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2022 | 57 | 0.190 |
Why?
|
| Biodiversity | 1 | 2021 | 64 | 0.180 |
Why?
|
| Genital Neoplasms, Female | 1 | 2021 | 46 | 0.180 |
Why?
|
| Bacteria | 2 | 2021 | 485 | 0.170 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2020 | 29 | 0.170 |
Why?
|
| Metagenomics | 1 | 2021 | 105 | 0.170 |
Why?
|
| Cervix Uteri | 1 | 2020 | 70 | 0.170 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 475 | 0.160 |
Why?
|
| Microbiota | 2 | 2021 | 392 | 0.160 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 1696 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 288 | 0.150 |
Why?
|
| Feces | 1 | 2021 | 715 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 573 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 871 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 656 | 0.120 |
Why?
|
| Neoplasms | 1 | 2024 | 2786 | 0.080 |
Why?
|
| Middle Aged | 4 | 2021 | 26363 | 0.080 |
Why?
|
| Female | 7 | 2024 | 66269 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 544 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2021 | 6086 | 0.060 |
Why?
|
| Oncolytic Viruses | 1 | 2024 | 72 | 0.060 |
Why?
|
| Humans | 7 | 2024 | 124243 | 0.050 |
Why?
|
| Mucus | 1 | 2022 | 36 | 0.050 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2022 | 19 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 888 | 0.050 |
Why?
|
| Human papillomavirus 16 | 1 | 2022 | 48 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 189 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 39 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 113 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 70 | 0.040 |
Why?
|
| Comamonadaceae | 1 | 2020 | 2 | 0.040 |
Why?
|
| Gardnerella | 1 | 2020 | 3 | 0.040 |
Why?
|
| Clostridiales | 1 | 2020 | 9 | 0.040 |
Why?
|
| Proteobacteria | 1 | 2020 | 19 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 106 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2020 | 43 | 0.040 |
Why?
|
| Botswana | 1 | 2020 | 76 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2024 | 663 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 267 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 422 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 474 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3336 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2022 | 821 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 29351 | 0.030 |
Why?
|
| Prognosis | 1 | 2022 | 4547 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1676 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6253 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 17750 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12260 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 34147 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 19383 | 0.010 |
Why?
|